Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosis
Open Access
- 10 March 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1552426
Abstract
Background: Aberrant hypermethylation of genomic DNA CpG islands (CGIs) is frequently observed in human pancreatic cancer (PAC). A plasma cell-free DNA (cfDNA) methylation analysis method can be utilized for the early and noninvasive detection of PAC. This study also aimed to differentiate PAC from other cancer types.Methods: We employed the methylated CpG tandem amplification and sequencing (MCTA-Seq) method, which targets approximately one-third of CGIs, on plasma samples from PAC patients (n = 50) and healthy controls (n = 52), as well as from cancerous and adjacent noncancerous tissue samples (n = 66). The method’s efficacy in detecting PAC and distinguishing it from hepatocellular carcinoma (HCC), colorectal cancer (CRC), and gastric cancer (GC) was evaluated. Additionally, a methylation score and typing system for PAC was also established.Results: We identified a total of 120 cfDNA methylation biomarkers, including IRX4, KCNS2, and RIMS4, for the detection of PAC in blood. A panel comprising these biomarkers achieved a sensitivity of 97% and 86% for patients in the discovery and validation cohorts, respectively, with a specificity of 100% in both cohorts. The methylation scoring and typing systems were clinically applicable. Furthermore, we identified hundreds of differentially methylated cfDNA biomarkers between PAC and HCC, CRC, and GC. Certain combinations of these markers can be used in a highly specific (approximately 100%) algorithm to differentiate PAC from HCC, CRC, and GC in blood.Conclusions: Our study identified cfDNA methylation markers for PAC, offering a novel approach for the early, noninvasive diagnosis of PAC.Keywords
This publication has 68 references indexed in Scilit:
- KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3/Akt/mTOR pathwayCellular and Molecular Life Sciences, 2024
- Investigating the prognostic role of lncRNAs associated with disulfidptosis‐related genes in clear cell renal cell carcinomaThe Journal of Gene Medicine, 2023
- Exploring oncogenes for renal clear cell carcinoma based on G protein-coupled receptor-associated genesDiscover Oncology, 2023
- Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studiesAnnals of Oncology, 2023
- Development of cancer-associated fibroblasts subtype and prognostic model in gastric cancer and the landscape of tumor microenvironmentThe International Journal of Biochemistry & Cell Biology, 2022
- Whole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancerClinical and Translational Medicine, 2022
- Analysis and Performance Assessment of the Whole Genome Bisulfite Sequencing Data Workflow: Currently Available Tools and a Practical Guide to Advance DNA Methylation StudiesSmall Methods, 2022
- Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoterBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021
- Modified Forms of Cytosine in Eukaryotes: DNA (De)methylation and Beyond2020
- Methylation Analysis by DNA Immunoprecipitation (MeDIP)2009